News DermTech, Inc.

Equities

DMTK

US24984K1051

Delayed Nasdaq Other stock markets 09:46:27 2024-04-26 am EDT			5-day change	1st Jan Change
0.5801 ^USD	-0.91%		-6.83%	-65.71%

Apr. 22	North American Morning Briefing : Stock Futures -2-	DJ
Apr. 19	Lake Street Downgrades DermTech to Hold From Buy, Price Target is $0.63	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

North American Morning Briefing : Stock Futures -2-	Apr. 22	DJ
Lake Street Downgrades DermTech to Hold From Buy, Price Target is $0.63	Apr. 19	MT
BTIG Downgrades DermTech to Neutral From Buy	Apr. 19	MT
DermTech Explores Strategic Alternatives to Boost Shareholder Value, Lays Off 100 Employees in Restructuring Plan	Apr. 18	MT
DermTech to Explore Strategic Alternatives and Implement Restructuring Plan	Apr. 18	BU
DermTech to Explore Strategic Alternatives and Implement Restructuring Plan	Apr. 17	CI
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Apr. 01	BU
DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative Dermatology	Mar. 11	AQ
DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative Dermatology	Mar. 08	BU
BTIG Adjusts DermTech's Price Target to $2 From $4, Maintains Buy Rating	Mar. 07	MT
Stephens Trims Price Target on DermTech to $1.50 From $2.50, Keeps Equalweight Rating	Mar. 05	MT
DermTech : 2023 Q4 Transcript	Feb. 29	PU
Transcript : DermTech, Inc., Q4 2023 Earnings Call, Feb 29, 2024	Feb. 29
DermTech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
DermTech, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29	CI
Earnings Flash (DMTK) DERMTECH Reports Q4 Revenue $3.9M, vs. Street Est of $4.03M	Feb. 29	MT
DermTech Reports Fourth-Quarter 2023 Financial Results	Feb. 29	BU
DermTech Announces Release Date for Fourth-quarter 2023 Financial Results	Feb. 13	BU
DermTech Announces Additional Restructuring Actions to Focus on Revenue Growth and Streamline Operations	Jan. 31	BU
Dermtech, Inc. Announces Cessation of Claudia Ibarra as Chief Operating Officer	Jan. 31	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News DermTech, Inc.

Equities

DMTK

US24984K1051

Summary

Filters